News Conference News AHA 2016 Misdosing NOACs Common in Everyday Practice, With Implications for Stroke and Bleeding Shelley Wood November 21, 2016
News Conference News AHA 2016 Errar la Dosis de NOAC en la Práctica Clínica Diaria es algo Habitual, lo cual tiene Implicaciones en Materia de ACV y Hemorragias Shelley Wood November 21, 2016
News Daily News FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm Michael O'Riordan October 11, 2016
News Daily News Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation Michael O'Riordan October 07, 2016
News Daily News Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns Shelley Wood September 13, 2016
News Industry News St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation September 01, 2016
News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016
News Daily News FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors Michael O'Riordan August 18, 2016
News Daily News New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows Yael L. Maxwell August 10, 2016
News Daily News New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care Michael O'Riordan June 29, 2016
News Daily News Black Individuals Have Less A-fib, but When They Do, the Consequences Are More Dire Michael O'Riordan June 24, 2016
News Daily News Majority of FDA Advisors Give Green Light to Amplatzer PFO Closure Device for Stroke Shelley Wood May 25, 2016
Presentation EuroPCR 2016 LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage Presenter: Jens Erik Nielsen-Kudsk May 20, 2016
News Daily News Un Estudio del Mundo Real Confirma los Efectos de Apixaban y Rivaroxaban en el Manejo de la FA Todd Neale April 21, 2016
News Daily News Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib Todd Neale April 21, 2016
News Industry News Real-World Study Shows 72 Percent of Atrial Fibrillation Would Have Gone Undiagnosed in Stroke Patients if Cardiac Monitoring Had Been Limited to 30 Days April 20, 2016
News Industry News Stroke Prevention: BIOTRONIK Announces FDA Approval of BioMonitor 2 Insertable Cardiac Monitor April 12, 2016
News Conference News ACC 2016 Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding Todd Neale April 06, 2016